WHO/Q. Mattingly
© Credits

Antimicrobial resistance

    Overview

    Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

    AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.

    Antimicrobials - including antibiotics, antivirals, antifungals and antiparasitics - are medicines used to prevent and treat infections in humans, animals and plants. Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

    News

    All →

    Latest publications

    All →
    2023 Antibacterial agents in clinical and preclinical development: an overview and analysis

    The World Health Organization’s (WHO) “2023 Antibacterial agents in clinical and preclinical development: an overview and analysis” report...

    WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance

    The 2024 WHO Bacterial Priority Pathogens List (WHO BPPL) is an important tool in the global fight against antimicrobial resistance. Building on the 2017...

    The Platinum Decade: Accelerating health for billions: WHO South-East Asia Region 2014–2023

    This book documents WHO’s activities and accomplishments during the decade from 2014 to 2023. It highlights what can be achieved when WHO, its Member...

    Workshop on strengthening laboratory services for antimicrobial resistance (‎AMR)‎ surveillance in leprosy, 14–15 November 2022

    The WHO Global Leprosy Programme (GLP) reviewed the leprosy situation globally at a consultation in June 2021 [see Report of the virtual Consultation...

    Our work

    Documents

    All →

    Nepal: Second national action plan on antimicrobial resistance 2024-2028 (Nepali)

    The WHO Taskforce of AMR Survivors was established in 2023 to give a platform for and elevate the voices of those with experience of complications from...

    Involving patients and the public in antimicrobial resistance (AMR) is vital for a robust, holistic response. Patients, survivors and carers provide...

    Country profiles

    Country profiles

    Country profiles present selected data, statistics and information to provide national health profiles at given points in time.
    GO